abagovomab 29
abciximab 27
abituzumab 24
abrilumab 21
actoxumab 13
adalimumab 17
aducanumab 11
afasevikumab 17
alacizumab_pegol 11
alemtuzumab 28
alirocumab 22
amatuximab 40
andecaliximab 23
anifrolumab 21
anrukinzumab 17
aprutumab 17
aprutumab_ixadotin 17
arcitumomab 19
ascrinvacumab 7
atezolizumab 16
atinumab 16
avelumab 12
basiliximab 31
bavituximab 37
begelomab 23
benralizumab 29
bevacizumab_beta 22
bezlotoxumab 13
bimagrumab 19
bleselumab 17
blinatumomab 26
blosozumab 29
bococizumab 18
brazikumab 18
brentuximab_vedotin 34
briakinumab 19
brodalumab 11
brolucizumab 28
brontictuzumab 29
burosumab 20
cabiralizumab 29
camrelizumab 14
canakinumab 23
cantuzumab_ravtansin 42
carlumab 15
carotuximab 24
cergutuzumab_amunaleukin2 26
cergutuzumab_amunaleukin 26
certolizumab_pegol 27
cetiximab 40
citatuzumab_bogatox 28
cixutumumab 26
clivatuzumab_tetraxetan 19
codrituzumab 31
conatumumab 14
concizumab 28
crenezumab 22
crizanlizumab 28
crotedumab 21
dacetuzumab 24
daclizumab 18
dalotuzumab 31
dapirolizumab_pegol 26
daratumumab 13
dectrekumab 10
demcizumab 22
denosumab 8
depatuxizumab 24
depatuxizumab_mafodotin 24
dezamizumab 23
dinutuximab 32
diridavumab 21
domagrozumab 17
drozitumab 15
duligotuzumab 20
durvalumab 8
dusigitumab 21
efalizumab 35
efungumab 28
eldelumab 17
elezanumab 21
elgemtumab 13
elotuzumab 16
emactuzumab 21
emapalumab 28
emibetuzumab 20
enavatuzumab 24
enfortumab_vedotin 15
enoblituzumab 17
enokizumab 25
enoticumab 19
ensituximab 32
eptinezumab 16
erenumab 21
etaracizumab 15
etrolizumab 23
evinacumab 22
evolocumab 18
farletuzumab 3
fasinumab 24
fezakinumab 24
fibatuzumab 13
ficlatuzumab 25
firivumab 31
flanvotumab 18
fletikumab 24
foralumab 13
foravirumab 15
fremanezumab 29
fresolimumab 16
fulranumab 20
futuximab 18
galcanezumab 20
ganitumab 21
gantenerumab 14
gemetuzumab 32
gemtuzumab2 27
gemtuzumab 27
gevokizumab 21
girentuximab 29
glembatumumab 19
glembatumumab_vedotin 19
guselkumab 20
ibalizumab 29
ibritumomab 32
icrucumab 11
idarucizumab 31
ifabotuzumab 13
imalumab 18
imgatuzumab 23
inclacumab 21
indatuximab_ravtansin 27
indusatumab 19
inebilizumab 25
intetumumab 12
iodine_girentuximab 29
ipilimumab 7
iratumumab 15
isatuximab 33
itolizumab 22
ixekizumab 32
labetuzumab_govitecan 24
lambrolizumab 28
lampalizumab 27
lanadelumab 19
landogrozumab 19
laprituximab 29
lebrikizumab 37
lendalizumab 27
lenzilumab 18
lifastuzumab_vedotin 24
ligelizumab 23
lilotomab 38
lirilumab 25
lodelcizumab 20
lokivetmab 25
lorvotuzumab_mertansin 22
lucatumumab 31
lumretuzumab 19
lupartumab 17
lutikizumab 19
margetuximab 30
milatuzumab 38
mirvetuximab 31
mirvetuximab_soravtansin 31
modotuximab 40
mogamulizumab 28
monalizumab 23
motavizumab 34
moxetumomab_pasudotox 23
namilumab 24
naratuximab 29
naratuximab_emtansin 29
narnatumab 16
navicixizumab2 28
navicixizumab 24
navivumab 34
necitumumab 10
nemolizumab 27
nesvacumab 17
nivolumab 12
obiltoxaximab 21
obinutuzumab 31
ocaratuzumab 24
ofatumumab 19
olaratumab 18
olokizumab 24
omalizumab 22
onartuzumab 23
ontuxizumab 32
opicinumab 13
orticumab 13
otelixizumab 36
oxelumab 13
ozanezumab 33
pamrevlumab 13
panobacumab 24
parsatuzumab 29
pasotuxizumab 22
pateclizumab 18
patritumab 18
pembrolizumab 28
perakizumab 24
pidilizumab 15
pinatuzumab_vedotin 19
plozalizumab 26
pogalizumab 27
polatuzumab_vedotin 22
ponezumab 34
prezalumab 15
pritoxaximab 35
quilizumab 21
racotumomab 30
radretumab 14
ralpancizumab 23
ramucirumab 13
ranevetmab 30
ranibizumab 22
refanezumab 23
remtolumab 20
rilotumumab 15
rinucumab 17
risankizumab 31
rituximab 24
rivabazumab 23
robatumumab 20
roledumab 32
romosozumab 22
rontalizumab 24
rosmantuzumab 23
rozanolixizumab 22
sacituzumab 29
sacituzumab_govitecan 29
samalizumab 29
sapelizumab 24
sarilumab 17
secukinumab 15
seribantumab 16
setoxaximab 44
sifalimumab 13
siltuximab 17
simtuzumab 29
sirukumab 12
solanezumab 27
solitomab 28
stamulumab 18
suptavumab 22
suvizumab 21
tabalumab 15
tadocizumab 21
tamtuvetmab 35
tanezumab 23
tarextumab 11
tavolixizumab 13
telisotuzumab 30
teplizumab 23
tesidolumab 22
tezepelumab 25
tigatuzumab 16
tildrakizumab 23
timolumab 14
tisotumab 11
tosatoxumab 33
tositumomab 29
tralokinumab 26
trastuzumab 24
tregalizumab 22
trevogrumab 12
ublituximab 27
urelumab 20
ustekinumab 28
utomilumab 26
vadastuximab 27
vadastuximab_talirin 27
vandortuzumab_vedotin 21
vantictumab 19
vanucizumab2 22
vanucizumab 31
varlilumab 16
vatelizumab 19
vedolizumab 28
veltuzumab 17
vesencumab 10
vorsetuzumab 22
vorsetuzumab_mafodotin 22
vunakizumab 31
xentuzumab 17
zatuximab 40
